Resumo
Definición
Anamnesis y examen
Principales factores de diagnóstico
- lesões cutâneas
Otros factores de diagnóstico
- história familiar
- edema ou dor em articulação
Factores de riesgo
- genética
- infecção
- trauma local
- medicações
- estresse
- tabagismo
- etnia
- bebidas alcoólicas
- índice de massa corporal (IMC) mais elevado
Pruebas diagnósticas
Primeras pruebas diagnósticas para solicitar
- diagnóstico clínico
Pruebas diagnósticas que deben considerarse
- biópsia de pele
Algoritmo de tratamiento
em placas
gutata
pustular
Colaboradores
Autores
Andrea Chiricozzi, MD
Assistant Professor
University of Pisa
Consultant Dermatologist
University Hospital of Pisa
Pisa
Italy
Divulgaciones
AC has served as an advisory board member and consultant and has received fees and speaker's honoraria or has participated in clinical trials for AbbVie, Almirall, Biogen, Fresenius Kabi, Leo Pharma, Lilly, Janssen, Novartis, Sanofi Genzyme, and UCB Pharma; AC is also an author of a reference cited in this topic.
Agradecimientos
Dr Andrea Chiricozzi would like to gratefully acknowledge Dr April W. Armstrong and Dr Tsu-Yi Chuang, previous contributors to this topic.
Divulgaciones
TC declares that he has no competing interests. AWA is an investigator and consultant for Abbott, Amgen, and Janssen; AWA is also an author of references cited in this topic.
Revisores por pares
David Burden, MD, FRCP
Western Infirmary, Glasgow
Consultant Dermatologist Dermatology
Glasgow
UK
Divulgaciones
DB has been reimbursed as a consultant, researcher, and lecturer for Abbott, Leo, Pfizer, Merck, Janssen-Cilag, and Novartis.
Paradi Mirmirani, MD
Physician
Department of Dermatology
Kaiser Permanente Vallejo Medical Center
Vallejo
CA
Divulgaciones
PM declares that she has no competing interests.
Referencias
Artículos principales
National Institute for Health and Care Excellence. Psoriasis: assessment and management. September 2017 [internet publication].Texto completo
Smith CH, Yiu ZZN, Bale T, et al. British Association of Dermatologists guidelines for biologic therapy for psoriasis 2020: a rapid update. Br J Dermatol. 2020 Oct;183(4):628-37.Texto completo Resumen
Elmets CA, Lim HW, Stoff B, et al. Joint American Academy of Dermatology – National Psoriasis Foundation guidelines of care for the management and treatment of psoriasis with phototherapy. J Am Acad Dermatol. 2019 Sep;81(3):775-804.Texto completo Resumen
Menter A, Gelfand JM, Connor C, et al. Joint American Academy of Dermatology - National Psoriasis Foundation guidelines of care for the management of psoriasis with systemic nonbiologic therapies. J Am Acad Dermatol. 2020 Jun;82(6):1445-86.Texto completo Resumen
Artículos de referencia
Una lista completa de las fuentes a las que se hace referencia en este tema está disponible para los usuarios con acceso a todo BMJ Best Practice.
Diferenciales
- Eczema
- Pitiríase rósea
- Dermatite seborreica
Más DiferencialesGuías de práctica clínica
- EuroGuiDerm guideline on the systemic treatment of psoriasis vulgaris – part 2: specific clinical and comorbid situations
- Joint AAD-NPF guidelines of care for the management and treatment of psoriasis with topical therapy and alternative medicine modalities for psoriasis severity measures
Más Guías de práctica clínicaFolletos para el paciente
Psoríase: quais são as opções de tratamento?
Psoríase: o que é?
Más Folletos para el pacienteCalculadoras
Índice de intensidade e de área da psoríase (PASI; Psoriasis Area and Severity Index)
Más Calculadoras
Inicie sesión o suscríbase para acceder a todo el BMJ Best Practice
El uso de este contenido está sujeto a nuestra cláusula de exención de responsabilidad